FDA Inspection 934536 — Theravance Biopharma US, Inc.
The FDA completed an inspection of Theravance Biopharma US, Inc. on Jun 26, 2015 in South San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 26, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South San Francisco, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)